Although the healthcare industry has shown significant resilience, the byproduct of the pandemic has amplified staff stressors across all operational and clinical roles. In a study conducted in 2022, more than one-third (34%) of the participating registered nurses (RN) stated that it was likely they would leave bedside nursing by the end of the year. Almost half (44%) cited both burnout and high-stress environments as their main reasons to retire or pursue other careers.
As staff
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards
What You Should Know:
Epic, Nordic, Impact Advisors and The Chartis Group won the 2023 Overall Best in KLAS® awards. Epic was named the top Overall Software Suite for the thirteenth straight year in 2023 Best in KLAS – Software & Services report, released, which reports on the top vendors for 2022. Epic was also named the top Overall Physician Practice Vendor. Epic won thirteen other Best in KLAS awards in various market segments.
- Impact Advisors tied with Nordic to be a
Read More
Biden Admin Builds on Cancer Moonshot with 13 More Initiatives
What You Should Know:
- One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today.
- The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More
Is AI-Assisted Lung Cancer Diagnosis Right For Your Hospital?
Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from this disease each year. Most patients are diagnosed after symptoms have appeared and the disease has progressed to an advanced stage (Stage III or IV), which explains the current worldwide five-year survival rate of just 20 percent. In contrast, the survival rate for small lung tumors that are treated at Stage 1A is as high as 90 percent. This significant difference highlights a critical
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.
There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
17 Executive Hospital/Health System Predictions to Watch in 2023
Vijay Kedar, Co-Founder and CEO at Tomorrow Health
Health systems will realize their challenges are not transitory but systemic: This year saw health systems facing a myriad of compounding threats – from historic inflation exacerbating their cost structures, front-line clinician burnout driving widespread labor shortages, and increased capacity issues that left patients in hospital facilities one full day longer than in the prior year. As the financial markets turned south, many institutions
Read More
2022 Healthcare Investment, M&A, IPO Market Trends/Insights
What You Should Know:
- The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each.
- Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market.
Trends and Insights – Healthcare
Read More
6 Executive Health Data Predictions to Watch in 2023
Kevin Agatstein, CEO at Kaid Health
In 2023 I predict that unstructured medical data, which makes up the majority of a patient’s chart, will become too valuable to ignore by both providers and payers. Driven in part by the growth of Medicare Advantage and oncology, both of which require the data within medical notes rather than just claims and labs data, organizations will start to use their unstructured EMR data in entirely new ways.
Rob Cohen, CEO at Bamboo Health
In today’s
Read More
Caris Life Sciences and ConcertAI Partner to Accelerate Drug Development and Novel Research
What You Should Know:
- Caris Life Sciences®(Caris), a molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, an oncology real-world evidence data and AI technology company, announced a unique partnership to align the two companies' oncology capabilities.
- The strategic partnership will create one of the largest translational and clinical
Read More
C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
What You Should Know:
- C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader.
- The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers.
- Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
